Evidence map›Paper›PMID 32967634›Full record

ArticleBMC cancer2020

Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma.

Wong Hoi She, Tan To Cheung, Ka Wing Ma, Simon H Y Tsang, Wing Chiu Dai, Albert C Y Chan, Chung Mau Lo

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Moving forward in the treatment of cholangiocarcinoma.World journal of gastrointestinal oncology · 2021
    Review
  10. The Landmark Series: Hilar Cholangiocarcinoma.Annals of surgical oncology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wong Hoi SheDepartment of Surgery, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.
Tan To CheungDepartment of Surgery, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China. tantocheung@hotmail.com.
Ka Wing MaDepartment of Surgery, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.
Simon H Y TsangDepartment of Surgery, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.
Wing Chiu DaiDepartment of Surgery, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.
Albert C Y ChanDepartment of Surgery, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.
Chung Mau LoDepartment of Surgery, The University of Hong Kong, 102 Pok Fu Lam Road, Hong Kong, China.
University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the management of operable hilar cholangiocarcinoma (HC) patients with hyperbilirubinemia, preoperative biliary drainage is a measure to bring down the bilirubin to a certain level so as to avoid adverse postoperative outcomes that would otherwise result from hyperbilirubinemia. A cutoff value of bilirubin level in this context is needed but has not been agreed upon without controversy. This retrospective study aimed to identify a cutoff of preoperative bilirubin level that would minimize postoperative morbidity and mortality.

methodsData of patients having hepatectomy with curative intent for HC were analyzed. Discriminative analysis was performed to identify the preoperative bilirubin level that would make a survival difference. The identified level was used as the cutoff to divide patients into two groups. The groups were compared.

resultsNinety patients received hepatectomy with curative intent for HC. Their median preoperative bilirubin level was 23 μmol/L. A cutoff preoperative bilirubin level of 75 μmol/L was derived from Youden's index (sensitivity 0.333; specificity 0.949) and confirmed to be optimal by logistic regression (relative risk 9.250; 95% confidence interval 1.932-44.291; p = 0.005), with mortality shown to be statistically different at 90 days (p = 0.008). Patients were divided into Group A (≤75 μmol/L; n = 82) and Group B (> 75 μmol/L; n = 8). Group B had a higher preoperative bilirubin level (p < 0.001), more intraoperative blood loss (3.12 vs 1.4 L; p = 0.008), transfusion (100% vs 42.0%; p = 0.011) and replacement (2.45 vs 0.0 L; p < 0.001), more postoperative renal complications (p = 0.036), more in-hospital deaths (50% vs 8.5%; p = 0.004), and more 90-day deaths (50% vs 9.8%; p = 0.008). Group A had a longer follow-up period (p = 0.008). The groups were otherwise comparable. Disease-free survival was similar between groups (p = 0.142) but overall survival was better in Group A (5-year, 25.2% vs 0%; p < 0.001). On multivariate analysis, preoperative bilirubin level and intraoperative blood replacement were risk factors for 90-day mortality.

conclusionA cutoff value of preoperative bilirubin level of 75 μmol/L is suggested, as the study showed that a preoperative bilirubin level ≤ 75 μmol/L resulted in significantly less blood replacement necessitated by blood loss during operation and significantly better patient survival after surgery.

Indexed as

AgedBile Duct NeoplasmsBilirubinCholangiocarcinomaFemaleHepatectomyHumansMaleBilirubinBilirubin levelERCPHepatectomyHilar cholangiocarcinomaPreoperative biliary drainagePTBD

Identifiers

PMID32967634
PMCPMC7513475
OpenAlexW3088597698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.